MarginsXMarginsX
Home › Markets › Health Care › CODX

Co-Diagnostics Inc. (CODX)

CODX trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$0.2249
-13.03% on the day
Market cap
$2.4M
Nano cap
Revenue · 2025
$622K
-84.1% on 2024
Net income · 2025
-$46.9M
-7533.6% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1692415/000149315226014158/0001493152-26-014158-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerCODX on Nasdaq
SectorHealth Care
IndustryMedical/Dental Instruments
CountryUnited States
IPO year2026
SEC CIK0001692415
SEC industry codeSurgical & Medical Instruments & Apparatus
Incorporated inUT

Financials · 2025

LineValue
Revenue$622K
Net income-$46.9M
Operating income-$50.2M
Net margin-7533.6%
Operating margin-8058.8%
Revenue growth-84.1%
Cash$11.9M
Total assets$24.7M
P/E (computed)Net income was not positive
P/S (computed)3.8×

Warning signs

Cash runway
0.3 months
$715K cash at September 30, 2026
Share count, 1 year
+417.9%
2025-11-11 to 2026-11-06 · +931.3% over 3 years
Going-concern doubt
Yes
10-Q filed November 10, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"As a result, management has concluded that substantial doubt exists about the Company's ability to continue as a going concern for 12 months from the date these condensed consolidated financial statements are issued. 7 The condensed consolidated financial statements as of September 30, 2026 have been prepared under the assumption that the Company will continue as a going concern for the next 12 months after these fin"
10-Q 2026-11-10
Cash and burn$715K cash; operating cash flow -$6.7M a quarter.Report 2026-09-30
Shares outstanding10,512,190 (2026-11-06); 60,892,582 a year earlier; 30,580,904 three years earlier. 1y figure adjusted for split (1-for-30 overall); 3y figure adjusted for split (1-for-30 overall).Cover page 2026-11-06
Reverse splits, 3 years1; latest 1-for-30 on 2026-01-02Source 2026-01-02
Shelf and offerings, 12 months4 S-3/F-3 shelf filings; 2 424B5 takedowns, 1 at the marketLatest 2026-07-27
Exchange deficiency notices, 12 months1 (8-K item 3.01)8-K 2026-01-13
AuditorTanner LLP, Salt Lake City, Utah, United StatesPCAOB Form AP 2026-04-03
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$283K-$6.3M-$5.7M$715KNo debt tags$859K10-Q 2026-11-10
Q2 2026
2026-06-30
$166K-$6.3M-$7.2M$3.6MNo debt tags$721K10-Q 2026-08-13
Q1 2026
2026-03-31
$146K-$9.1M-$7.8M$8.2MNo debt tags$718K10-Q 2026-05-14
Q4 2025
2025-12-31
$264K-$25.7M-$6.2M$11.9MNo debt tags$622K10-K 2026-03-31
Q3 2025
2025-09-30
$145K-$5.9M-$5.9M$11.4MNo debt tags$508K10-Q 2026-11-10
Q2 2025
2025-06-30
$163K-$7.7M-$8.3M$11.1MNo debt tags$1.0M10-Q 2026-08-13
Q1 2025
2025-03-31
$50K-$7.5M-$8.7M$1.9MNo debt tags$3.5M10-Q 2026-05-14
Q4 2024
2024-12-31
$149K-$11.0M-$8.2M$2.9MNo debt tags$3.9M10-K 2026-03-31

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering documentS-32026-11-04
Latest annual report10-K2026-03-31
Latest quarterly / interim10-Q2026-11-10
Latest current report8-K2026-11-13
Latest proxyDEF 14A2026-10-26

Source: SEC EDGAR submissions feed, 393 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+0.8%
1 month-75.7%
3 months-82.6%
Year to date-94.9%
1 year-97.7%
From 52-week high-97.8%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medical/Dental Instruments

TickerCompanyPriceDayMarket cap
AMIXAutonomix Medical Inc.$1.10-19.71%$2.2M
BJDXBluejay Diagnostics Inc.$2.29-12.26%$2.6M
ICCMIceCure Medical Ltd.$0.7601+4.12%$2.6M
IVFINVO Fertility Inc.$2.40-7.69%$2.8M
VVOSVivos Therapeutics Inc.$0.0822-16.12%$2.8M
NXGLNexGel Inc$3.93+2.08%$1.9M
XAIRBeyond Air Inc.$2.02-5.16%$3.4M
TNONTenon Medical Inc.$1.33-5.32%$3.6M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier